Inactive Instrument

22nd Century Group Stock Nyse

Equities

Tobacco

Sales 2022 62.11M Sales 2023 21.79M Capitalization 8.15M
Net income 2022 -59M Net income 2023 -141M EV / Sales 2022 2.96 x
Net cash position 2022 14.48M Net Debt 2023 14.32M EV / Sales 2023 1.03 x
P/E ratio 2022
-2.97 x
P/E ratio 2023
-0.03 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 92.41%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 66 Nov. 27
Chief Tech/Sci/R&D Officer - 17-12-30
Corporate Officer/Principal 59 22-09-29
Members of the board TitleAgeSince
Director/Board Member 77 22-09-11
Chief Executive Officer 66 Nov. 27
Director/Board Member 64 23-07-18
More insiders
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
Sector
Tobacco
More about the company